FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...